img

Global Oral Cytotoxic Drug Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Cytotoxic Drug Market Insights, Forecast to 2034

Oral Cytotoxic Drug is a cytotoxic drug administered by the oral route for the treatment of cancer and other cell proliferative diseases. These drugs act on abnormally proliferating cells in the body, inhibiting their growth and division, so as to achieve therapeutic effects. Oral Cytotoxic Drug provides a convenient treatment option that can reduce the patient's hospital stay and inconvenience of medical procedures.
Market Analysis and InsightsGlobal Oral Cytotoxic Drug Market
Global Oral Cytotoxic Drug market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Oral Cytotoxic Drug industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Oral Cytotoxic Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Oral Cytotoxic Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Amgen
Eli Lilly and Company
CytoPharma
Celgene
Bristol-Myers Squibb
Novasep Holding
Lonza Group
Cambrex Corporation
Piramal Group
Baxter Biopharma Solutions
Evonik Industries
Segment by Type
Alkylating Agents
Antitumor Antibiotics
Antimetabolites
Plant Alkaloids
Others

Segment by Application


Hospitals
Cancer Research Centres
Drug Testing Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Oral Cytotoxic Drug introduction, etc. Oral Cytotoxic Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Oral Cytotoxic Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Cytotoxic Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Alkylating Agents
1.2.3 Antitumor Antibiotics
1.2.4 Antimetabolites
1.2.5 Plant Alkaloids
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oral Cytotoxic Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Cancer Research Centres
1.3.4 Drug Testing Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Cytotoxic Drug Market Perspective (2018-2029)
2.2 Global Oral Cytotoxic Drug Growth Trends by Region
2.2.1 Oral Cytotoxic Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oral Cytotoxic Drug Historic Market Size by Region (2018-2024)
2.2.3 Oral Cytotoxic Drug Forecasted Market Size by Region (2024-2029)
2.3 Oral Cytotoxic Drug Market Dynamics
2.3.1 Oral Cytotoxic Drug Industry Trends
2.3.2 Oral Cytotoxic Drug Market Drivers
2.3.3 Oral Cytotoxic Drug Market Challenges
2.3.4 Oral Cytotoxic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Oral Cytotoxic Drug by Players
3.1.1 Global Oral Cytotoxic Drug Revenue by Players (2018-2024)
3.1.2 Global Oral Cytotoxic Drug Revenue Market Share by Players (2018-2024)
3.2 Global Oral Cytotoxic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Oral Cytotoxic Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Oral Cytotoxic Drug Market Concentration Ratio
3.4.1 Global Oral Cytotoxic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Cytotoxic Drug Revenue in 2022
3.5 Global Key Players of Oral Cytotoxic Drug Head office and Area Served
3.6 Global Key Players of Oral Cytotoxic Drug, Product and Application
3.7 Global Key Players of Oral Cytotoxic Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Cytotoxic Drug Breakdown Data by Type
4.1 Global Oral Cytotoxic Drug Historic Market Size by Type (2018-2024)
4.2 Global Oral Cytotoxic Drug Forecasted Market Size by Type (2024-2029)
5 Oral Cytotoxic Drug Breakdown Data by Application
5.1 Global Oral Cytotoxic Drug Historic Market Size by Application (2018-2024)
5.2 Global Oral Cytotoxic Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oral Cytotoxic Drug Market Size (2018-2029)
6.2 North America Oral Cytotoxic Drug Market Size by Type
6.2.1 North America Oral Cytotoxic Drug Market Size by Type (2018-2024)
6.2.2 North America Oral Cytotoxic Drug Market Size by Type (2024-2029)
6.2.3 North America Oral Cytotoxic Drug Market Share by Type (2018-2029)
6.3 North America Oral Cytotoxic Drug Market Size by Application
6.3.1 North America Oral Cytotoxic Drug Market Size by Application (2018-2024)
6.3.2 North America Oral Cytotoxic Drug Market Size by Application (2024-2029)
6.3.3 North America Oral Cytotoxic Drug Market Share by Application (2018-2029)
6.4 North America Oral Cytotoxic Drug Market Size by Country
6.4.1 North America Oral Cytotoxic Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Oral Cytotoxic Drug Market Size by Country (2018-2024)
6.4.3 North America Oral Cytotoxic Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Oral Cytotoxic Drug Market Size (2018-2029)
7.2 Europe Oral Cytotoxic Drug Market Size by Type
7.2.1 Europe Oral Cytotoxic Drug Market Size by Type (2018-2024)
7.2.2 Europe Oral Cytotoxic Drug Market Size by Type (2024-2029)
7.2.3 Europe Oral Cytotoxic Drug Market Share by Type (2018-2029)
7.3 Europe Oral Cytotoxic Drug Market Size by Application
7.3.1 Europe Oral Cytotoxic Drug Market Size by Application (2018-2024)
7.3.2 Europe Oral Cytotoxic Drug Market Size by Application (2024-2029)
7.3.3 Europe Oral Cytotoxic Drug Market Share by Application (2018-2029)
7.4 Europe Oral Cytotoxic Drug Market Size by Country
7.4.1 Europe Oral Cytotoxic Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Oral Cytotoxic Drug Market Size by Country (2018-2024)
7.4.3 Europe Oral Cytotoxic Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Oral Cytotoxic Drug Market Size (2018-2029)
8.2 China Oral Cytotoxic Drug Market Size by Type
8.2.1 China Oral Cytotoxic Drug Market Size by Type (2018-2024)
8.2.2 China Oral Cytotoxic Drug Market Size by Type (2024-2029)
8.2.3 China Oral Cytotoxic Drug Market Share by Type (2018-2029)
8.3 China Oral Cytotoxic Drug Market Size by Application
8.3.1 China Oral Cytotoxic Drug Market Size by Application (2018-2024)
8.3.2 China Oral Cytotoxic Drug Market Size by Application (2024-2029)
8.3.3 China Oral Cytotoxic Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Oral Cytotoxic Drug Market Size (2018-2029)
9.2 Asia Oral Cytotoxic Drug Market Size by Type
9.2.1 Asia Oral Cytotoxic Drug Market Size by Type (2018-2024)
9.2.2 Asia Oral Cytotoxic Drug Market Size by Type (2024-2029)
9.2.3 Asia Oral Cytotoxic Drug Market Share by Type (2018-2029)
9.3 Asia Oral Cytotoxic Drug Market Size by Application
9.3.1 Asia Oral Cytotoxic Drug Market Size by Application (2018-2024)
9.3.2 Asia Oral Cytotoxic Drug Market Size by Application (2024-2029)
9.3.3 Asia Oral Cytotoxic Drug Market Share by Application (2018-2029)
9.4 Asia Oral Cytotoxic Drug Market Size by Region
9.4.1 Asia Oral Cytotoxic Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Oral Cytotoxic Drug Market Size by Region (2018-2024)
9.4.3 Asia Oral Cytotoxic Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Oral Cytotoxic Drug Introduction
11.1.4 Amgen Revenue in Oral Cytotoxic Drug Business (2018-2024)
11.1.5 Amgen Recent Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Oral Cytotoxic Drug Introduction
11.2.4 Eli Lilly and Company Revenue in Oral Cytotoxic Drug Business (2018-2024)
11.2.5 Eli Lilly and Company Recent Developments
11.3 CytoPharma
11.3.1 CytoPharma Company Details
11.3.2 CytoPharma Business Overview
11.3.3 CytoPharma Oral Cytotoxic Drug Introduction
11.3.4 CytoPharma Revenue in Oral Cytotoxic Drug Business (2018-2024)
11.3.5 CytoPharma Recent Developments
11.4 Celgene
11.4.1 Celgene Company Details
11.4.2 Celgene Business Overview
11.4.3 Celgene Oral Cytotoxic Drug Introduction
11.4.4 Celgene Revenue in Oral Cytotoxic Drug Business (2018-2024)
11.4.5 Celgene Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Oral Cytotoxic Drug Introduction
11.5.4 Bristol-Myers Squibb Revenue in Oral Cytotoxic Drug Business (2018-2024)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Novasep Holding
11.6.1 Novasep Holding Company Details
11.6.2 Novasep Holding Business Overview
11.6.3 Novasep Holding Oral Cytotoxic Drug Introduction
11.6.4 Novasep Holding Revenue in Oral Cytotoxic Drug Business (2018-2024)
11.6.5 Novasep Holding Recent Developments
11.7 Lonza Group
11.7.1 Lonza Group Company Details
11.7.2 Lonza Group Business Overview
11.7.3 Lonza Group Oral Cytotoxic Drug Introduction
11.7.4 Lonza Group Revenue in Oral Cytotoxic Drug Business (2018-2024)
11.7.5 Lonza Group Recent Developments
11.8 Cambrex Corporation
11.8.1 Cambrex Corporation Company Details
11.8.2 Cambrex Corporation Business Overview
11.8.3 Cambrex Corporation Oral Cytotoxic Drug Introduction
11.8.4 Cambrex Corporation Revenue in Oral Cytotoxic Drug Business (2018-2024)
11.8.5 Cambrex Corporation Recent Developments
11.9 Piramal Group
11.9.1 Piramal Group Company Details
11.9.2 Piramal Group Business Overview
11.9.3 Piramal Group Oral Cytotoxic Drug Introduction
11.9.4 Piramal Group Revenue in Oral Cytotoxic Drug Business (2018-2024)
11.9.5 Piramal Group Recent Developments
11.10 Baxter Biopharma Solutions
11.10.1 Baxter Biopharma Solutions Company Details
11.10.2 Baxter Biopharma Solutions Business Overview
11.10.3 Baxter Biopharma Solutions Oral Cytotoxic Drug Introduction
11.10.4 Baxter Biopharma Solutions Revenue in Oral Cytotoxic Drug Business (2018-2024)
11.10.5 Baxter Biopharma Solutions Recent Developments
11.11 Evonik Industries
11.11.1 Evonik Industries Company Details
11.11.2 Evonik Industries Business Overview
11.11.3 Evonik Industries Oral Cytotoxic Drug Introduction
11.11.4 Evonik Industries Revenue in Oral Cytotoxic Drug Business (2018-2024)
11.11.5 Evonik Industries Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oral Cytotoxic Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Alkylating Agents
Table 3. Key Players of Antitumor Antibiotics
Table 4. Key Players of Antimetabolites
Table 5. Key Players of Plant Alkaloids
Table 6. Key Players of Others
Table 7. Global Oral Cytotoxic Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Oral Cytotoxic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Oral Cytotoxic Drug Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global Oral Cytotoxic Drug Market Share by Region (2018-2024)
Table 11. Global Oral Cytotoxic Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Oral Cytotoxic Drug Market Share by Region (2024-2029)
Table 13. Oral Cytotoxic Drug Market Trends
Table 14. Oral Cytotoxic Drug Market Drivers
Table 15. Oral Cytotoxic Drug Market Challenges
Table 16. Oral Cytotoxic Drug Market Restraints
Table 17. Global Oral Cytotoxic Drug Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global Oral Cytotoxic Drug Revenue Share by Players (2018-2024)
Table 19. Global Top Oral Cytotoxic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Cytotoxic Drug as of 2022)
Table 20. Global Oral Cytotoxic Drug Industry Ranking 2021 VS 2022 VS 2024
Table 21. Global 5 Largest Players Market Share by Oral Cytotoxic Drug Revenue (CR5 and HHI) & (2018-2024)
Table 22. Global Key Players of Oral Cytotoxic Drug, Headquarters and Area Served
Table 23. Global Key Players of Oral Cytotoxic Drug, Product and Application
Table 24. Global Key Players of Oral Cytotoxic Drug, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oral Cytotoxic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global Oral Cytotoxic Drug Revenue Market Share by Type (2018-2024)
Table 28. Global Oral Cytotoxic Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Oral Cytotoxic Drug Revenue Market Share by Type (2024-2029)
Table 30. Global Oral Cytotoxic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global Oral Cytotoxic Drug Revenue Share by Application (2018-2024)
Table 32. Global Oral Cytotoxic Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Oral Cytotoxic Drug Revenue Share by Application (2024-2029)
Table 34. North America Oral Cytotoxic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 35. North America Oral Cytotoxic Drug Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Oral Cytotoxic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 37. North America Oral Cytotoxic Drug Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Oral Cytotoxic Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Oral Cytotoxic Drug Market Size by Country (2018-2024) & (US$ Million)
Table 40. North America Oral Cytotoxic Drug Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Oral Cytotoxic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 42. Europe Oral Cytotoxic Drug Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Oral Cytotoxic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 44. Europe Oral Cytotoxic Drug Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Oral Cytotoxic Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Oral Cytotoxic Drug Market Size by Country (2018-2024) & (US$ Million)
Table 47. Europe Oral Cytotoxic Drug Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Oral Cytotoxic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 49. China Oral Cytotoxic Drug Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Oral Cytotoxic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 51. China Oral Cytotoxic Drug Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Oral Cytotoxic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 53. Asia Oral Cytotoxic Drug Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Oral Cytotoxic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 55. Asia Oral Cytotoxic Drug Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Oral Cytotoxic Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Oral Cytotoxic Drug Market Size by Region (2018-2024) & (US$ Million)
Table 58. Asia Oral Cytotoxic Drug Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Oral Cytotoxic Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Country (2018-2024) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size by Country (2024-2029) & (US$ Million)
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Oral Cytotoxic Drug Product
Table 69. Amgen Revenue in Oral Cytotoxic Drug Business (2018-2024) & (US$ Million)
Table 70. Amgen Recent Developments
Table 71. Eli Lilly and Company Company Details
Table 72. Eli Lilly and Company Business Overview
Table 73. Eli Lilly and Company Oral Cytotoxic Drug Product
Table 74. Eli Lilly and Company Revenue in Oral Cytotoxic Drug Business (2018-2024) & (US$ Million)
Table 75. Eli Lilly and Company Recent Developments
Table 76. CytoPharma Company Details
Table 77. CytoPharma Business Overview
Table 78. CytoPharma Oral Cytotoxic Drug Product
Table 79. CytoPharma Revenue in Oral Cytotoxic Drug Business (2018-2024) & (US$ Million)
Table 80. CytoPharma Recent Developments
Table 81. Celgene Company Details
Table 82. Celgene Business Overview
Table 83. Celgene Oral Cytotoxic Drug Product
Table 84. Celgene Revenue in Oral Cytotoxic Drug Business (2018-2024) & (US$ Million)
Table 85. Celgene Recent Developments
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Oral Cytotoxic Drug Product
Table 89. Bristol-Myers Squibb Revenue in Oral Cytotoxic Drug Business (2018-2024) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Developments
Table 91. Novasep Holding Company Details
Table 92. Novasep Holding Business Overview
Table 93. Novasep Holding Oral Cytotoxic Drug Product
Table 94. Novasep Holding Revenue in Oral Cytotoxic Drug Business (2018-2024) & (US$ Million)
Table 95. Novasep Holding Recent Developments
Table 96. Lonza Group Company Details
Table 97. Lonza Group Business Overview
Table 98. Lonza Group Oral Cytotoxic Drug Product
Table 99. Lonza Group Revenue in Oral Cytotoxic Drug Business (2018-2024) & (US$ Million)
Table 100. Lonza Group Recent Developments
Table 101. Cambrex Corporation Company Details
Table 102. Cambrex Corporation Business Overview
Table 103. Cambrex Corporation Oral Cytotoxic Drug Product
Table 104. Cambrex Corporation Revenue in Oral Cytotoxic Drug Business (2018-2024) & (US$ Million)
Table 105. Cambrex Corporation Recent Developments
Table 106. Piramal Group Company Details
Table 107. Piramal Group Business Overview
Table 108. Piramal Group Oral Cytotoxic Drug Product
Table 109. Piramal Group Revenue in Oral Cytotoxic Drug Business (2018-2024) & (US$ Million)
Table 110. Piramal Group Recent Developments
Table 111. Baxter Biopharma Solutions Company Details
Table 112. Baxter Biopharma Solutions Business Overview
Table 113. Baxter Biopharma Solutions Oral Cytotoxic Drug Product
Table 114. Baxter Biopharma Solutions Revenue in Oral Cytotoxic Drug Business (2018-2024) & (US$ Million)
Table 115. Baxter Biopharma Solutions Recent Developments
Table 116. Evonik Industries Company Details
Table 117. Evonik Industries Business Overview
Table 118. Evonik Industries Oral Cytotoxic Drug Product
Table 119. Evonik Industries Revenue in Oral Cytotoxic Drug Business (2018-2024) & (US$ Million)
Table 120. Evonik Industries Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Cytotoxic Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Oral Cytotoxic Drug Market Share by Type: 2022 VS 2029
Figure 3. Alkylating Agents Features
Figure 4. Antitumor Antibiotics Features
Figure 5. Antimetabolites Features
Figure 6. Plant Alkaloids Features
Figure 7. Others Features
Figure 8. Global Oral Cytotoxic Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Oral Cytotoxic Drug Market Share by Application: 2022 VS 2029
Figure 10. Hospitals Case Studies
Figure 11. Cancer Research Centres Case Studies
Figure 12. Drug Testing Laboratories Case Studies
Figure 13. Others Case Studies
Figure 14. Oral Cytotoxic Drug Report Years Considered
Figure 15. Global Oral Cytotoxic Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Oral Cytotoxic Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Oral Cytotoxic Drug Market Share by Region: 2022 VS 2029
Figure 18. Global Oral Cytotoxic Drug Market Share by Players in 2022
Figure 19. Global Top Oral Cytotoxic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Cytotoxic Drug as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Oral Cytotoxic Drug Revenue in 2022
Figure 21. North America Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Oral Cytotoxic Drug Market Share by Type (2018-2029)
Figure 23. North America Oral Cytotoxic Drug Market Share by Application (2018-2029)
Figure 24. North America Oral Cytotoxic Drug Market Share by Country (2018-2029)
Figure 25. United States Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Oral Cytotoxic Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Oral Cytotoxic Drug Market Share by Type (2018-2029)
Figure 29. Europe Oral Cytotoxic Drug Market Share by Application (2018-2029)
Figure 30. Europe Oral Cytotoxic Drug Market Share by Country (2018-2029)
Figure 31. Germany Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Oral Cytotoxic Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Oral Cytotoxic Drug Market Share by Type (2018-2029)
Figure 39. China Oral Cytotoxic Drug Market Share by Application (2018-2029)
Figure 40. Asia Oral Cytotoxic Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Oral Cytotoxic Drug Market Share by Type (2018-2029)
Figure 42. Asia Oral Cytotoxic Drug Market Share by Application (2018-2029)
Figure 43. Asia Oral Cytotoxic Drug Market Share by Region (2018-2029)
Figure 44. Japan Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Oral Cytotoxic Drug Market Share by Country (2018-2029)
Figure 54. Brazil Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Oral Cytotoxic Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Amgen Revenue Growth Rate in Oral Cytotoxic Drug Business (2018-2024)
Figure 61. Eli Lilly and Company Revenue Growth Rate in Oral Cytotoxic Drug Business (2018-2024)
Figure 62. CytoPharma Revenue Growth Rate in Oral Cytotoxic Drug Business (2018-2024)
Figure 63. Celgene Revenue Growth Rate in Oral Cytotoxic Drug Business (2018-2024)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Oral Cytotoxic Drug Business (2018-2024)
Figure 65. Novasep Holding Revenue Growth Rate in Oral Cytotoxic Drug Business (2018-2024)
Figure 66. Lonza Group Revenue Growth Rate in Oral Cytotoxic Drug Business (2018-2024)
Figure 67. Cambrex Corporation Revenue Growth Rate in Oral Cytotoxic Drug Business (2018-2024)
Figure 68. Piramal Group Revenue Growth Rate in Oral Cytotoxic Drug Business (2018-2024)
Figure 69. Baxter Biopharma Solutions Revenue Growth Rate in Oral Cytotoxic Drug Business (2018-2024)
Figure 70. Evonik Industries Revenue Growth Rate in Oral Cytotoxic Drug Business (2018-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed